ANDA 62845, held by Quad Pharms. Vancomycin Hydrochloride.
As of Nov 15, 2026, ANDA 62845 (Vancomycin Hcl), held by Quad Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Vancomycin HclEQ 500MG BASE/VIAL · injectable; injection | Vancomycin Hydrochloride | Discontinued |
| Vancomycin HclEQ 1GM BASE/VIAL · injectable; injection | Vancomycin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters